These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7906271)

  • 21. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I.
    Hovde CJ; Calderwood SB; Mekalanos JJ; Collier RJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2568-72. PubMed ID: 3357883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine.
    Gordon VM; Whipp SC; Moon HW; O'Brien AD; Samuel JE
    Infect Immun; 1992 Feb; 60(2):485-90. PubMed ID: 1730480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
    Acheson DW; Calderwood SB; Boyko SA; Lincicome LL; Kane AV; Donohue-Rolfe A; Keusch GT
    Infect Immun; 1993 Mar; 61(3):1098-104. PubMed ID: 8432592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and sequence analysis of another Shiga-like toxin IIe variant gene (slt-IIera) from an Escherichia coli R107 strain isolated from rabbit.
    Kim SH; Cha IH; Kim KS; Kim YH; Lee YC
    Microbiol Immunol; 1997; 41(10):805-8. PubMed ID: 9403506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
    Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
    Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL
    Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of recombinant shiga-like toxin type I B subunit.
    Austin PR; Hovde CJ
    Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
    Kongmuang U
    Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and purification of Shiga-like toxin II B subunits.
    Acheson DW; De Breucker SA; Jacewicz M; Lincicome LL; Donohue-Rolfe A; Kane AV; Keusch GT
    Infect Immun; 1995 Jan; 63(1):301-8. PubMed ID: 7806370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    Infect Immun; 1991 Mar; 59(3):829-35. PubMed ID: 1997433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279.
    Meyer T; Karch H; Hacker J; Bocklage H; Heesemann J
    Zentralbl Bakteriol; 1992 Jan; 276(2):176-88. PubMed ID: 1559006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli heat-labile enterotoxin. Evidence for a catalytic role for glutamic acid 112.
    Cieplak W; Mead DJ; Messer RJ; Grant CC
    J Biol Chem; 1995 Dec; 270(51):30545-50. PubMed ID: 8530486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.
    Tesh VL; Burris JA; Owens JW; Gordon VM; Wadolkowski EA; O'Brien AD; Samuel JE
    Infect Immun; 1993 Aug; 61(8):3392-402. PubMed ID: 8335369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and nucleotide sequence of a variant Shiga-like toxin II gene from Escherichia coli OX3:H21 isolated from a case of sudden infant death syndrome.
    Paton AW; Paton JC; Heuzenroeder MW; Goldwater PN; Manning PA
    Microb Pathog; 1992 Sep; 13(3):225-36. PubMed ID: 1291844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells.
    Garred O; Dubinina E; Polesskaya A; Olsnes S; Kozlov J; Sandvig K
    J Biol Chem; 1997 Apr; 272(17):11414-9. PubMed ID: 9111051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
    Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
    Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of mutant genes for a non-toxic verotoxin 2 variant (VT2vp1) of Escherichia coli and characterization of purified mutant toxins.
    Cao C; Kurazono H; Yamasaki S; Kashiwagi K; Igarashi K; Takeda Y
    Microbiol Immunol; 1994; 38(6):441-7. PubMed ID: 7968674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of recombinant Shiga-like toxin-IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status of pigs.
    Franke S; Gunzer F; Wieler LH; Baljer G; Karch H
    Vet Microbiol; 1995 Jan; 43(1):41-52. PubMed ID: 7716883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.
    Ito H; Terai A; Kurazono H; Takeda Y; Nishibuchi M
    Microb Pathog; 1990 Jan; 8(1):47-60. PubMed ID: 2185397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.